NCT05977179Toboroz
Dietary Intervention to Mitigate Post-Acute COVID-19 Syndrome
A Diet Intervention Study To Mitigate Fatigue Symptoms And To Improve Muscle And Physical Function In Older Adults With Post-Acute COVID-19 Syndrome
Forrás: ClinicalTrials.gov · Utoljára frissítve: 2026. jún. 23.
Rövid összefoglaló (regiszter, angolul)
The primary objective of this study is to conduct a 16-week randomized controlled trial aimed at investigating the effectiveness of the Whole-Diet Approach when following a healthy US-style diet rich in anti-inflammatory properties. The study will focus on evaluating its impact on reducing symptoms related to Post-Acute Sequelae of SARS-CoV-2 Infection (PACS) in adults aged 50 years and older. The main research questions this study aims to answer are: 1. Does adhering to a healthy US-style diet, which is abundant in anti-inflammatory properties, effectively mitigate fatigue symptoms in adults with PACS? 2. Does adhering to a healthy US-style diet, which is abundant in anti-inflammatory properties, effectively mitigate declines in muscle function and physical performance in adults with PACS? At the beginning of the study, eligible participants will be randomly assigned to either the Dietary Intervention Group, where they will receive personalized dietary plans and weekly sessions, or the Attention Control Group, where they will attend general health sessions on a weekly basis as well. This research intends to shed light on the potential benefits of the Whole-Diet Approach and its role in ameliorating PACS-related symptoms among older adults. By comparing the outcomes of the two groups, we hope to gain valuable insights into the effectiveness of this dietary intervention in improving the quality of life for individuals dealing with PACS.
- Állapot (regiszter)
- Toboroz
- Vizsgálattípus
- Beavatkozással járó
- Résztvevők száma
- 56 (tervezett)
- Első benyújtás
- 2023. júl. 28.
- Kezdés
- 2025. máj. 12.
- Elsődleges befejezés
- 2028. jún. 30.
- Fő szponzor
- University of Maryland, Baltimore
- Betegségek
- Long COVID és ME/CFS
- NCT-szám
- NCT05977179
Mit vállalsz
- Vizsgálat típusa: Beavatkozással járó
- Tervezett résztvevők: 56
- 2025. máj. 12. és az elsődleges befejezés (2028. jún. 30.) között
- 1 helyszín, 1 országban
- Vizitek és vizsgálatok: kérdezd a vizsgálat csapatát, a regiszter nem sorolja fel őket
A(z) ClinicalTrials.gov regisztermezőiből összeállítva. A vizsgálat felépítését írja le.
Ki nem vehet részt
Szó szerint a(z) ClinicalTrials.gov forrásból, témák szerint csoportosítva. Hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.
Korábbi kezelés
- Participants with dietary restrictions due to medication use that affects blood clotting, such as Warfarin or other reasons.
- Participation in another trial in which active intervention is being received.
- Participants with active drug or alcohol use/dependence that would interfere with adherence to the study.
- Participants scheduled for surgical procedures within the next 6 months.
Más betegség
- Participants diagnosed with Congestive Heart Failure (CHF New York Heart Association) > class 2
- Evidence of any condition as determined by a physician or the study team that would lead to an increased risk of illness due to any aspect of proposed testing and interventions, or introduce unanticipated confounding of study results.
- Participants diagnosed with uncontrolled hypertension that will be defined as:
- Systolic blood pressure consistently equal to or higher than 190 mmHg.
- Diastolic blood pressure consistently equal to or higher than 110 mmHg.
- Participants with a recent history of hypertensive crisis (severe elevation in blood pressure requiring immediate medical intervention), regardless of current blood pressure levels.
- Participants with diet restrictions or allergies that can affect adherence to the diet, such as allergy to fish or shellfish.
- Participants diagnosed with active cancer.
- Participants diagnosed with liver diseases.
- Participants diagnosed with kidney-related conditions, including Chronic Kidney Disease (CKD) > stage 3.
Laborértékek
- Participants diagnosed with diabetes who do not have a recent HbA1c level or with HbA1c > 9%
Életkor
- Below the age of 50 years.
Egyéb
- Participants with a home oxygen requirement or requiring chronic ventilator support
Kiket keres a vizsgálat
- Age of 50 years or older
- No known active infectious disease (COVID-19 or other).
- Participant diagnosed with long-COVID/ post- acute COVID-19 syndrome (PACS) /ICD-10-CM codes U09.9
- Moderate/severe fatigue Brief Fatigue Inventory (BFI)≥4
- Poor diet quality assessed by the short Healthy Eating Index (HEI)<70
Életkor a regiszterben: 50 év – 94 év · Nem: nők és férfiak · Egészséges önkénteseket nem fogad
Helyszínek (1)
Helyszínek a regiszter sorrendjében. Ha a profilodba mented a városodat, távolság szerint rendeződnek.
| Helyszín | Város | Ország | Helyszín állapota |
|---|---|---|---|
| University of Maryland, Baltimore | Baltimore | Egyesült Államok | Toboroz |
Ez az oldal tájékoztatás, nem orvosi tanács. Bármely vizsgálatról az orvosoddal beszélj.